|
INTRO |
|
HISTORY OF THIS RESEARCH
PROJECT |
|
|
|
History of This
Project AMA category I Continuing Medical Education
Conferences |
|
We have split the talk
into 3 slide show of about 10 megs each. |
|
Part 1 |
|
Part 2 |
|
Part 3 |
|
|
|
|
|
iBack
To Topntro1 |
|
INTRODUCTION TO
NEUROTRANSMITTER MOLECULES |
| Serotonin,
Dopamine, Norepinephrine and Epinephrine |
|
|
Introduction to
Neurotransmitters |
|
We have split the talk
into 4 slide show of about 10 megs each. |
|
Part 1 |
|
Part 2 |
|
Part 3 |
|
Part 4 |
|
|
|
|
|
|
depBack
To Topletion |
|
DEPLETION BY DRUGS - The
Reuptake inhibitor |
|
|
|
Neurotransmitter Depletion By Drugs |
|
We have split the talk
into 2 slide show of about 10 megs each. |
|
Part 1 |
|
Part 2 |
|
|
|
|
|
uBack
To Toprine |
|
URINARY
neurotransmitter testing LEVELS |
|
The model for neuron
bundle damage. |
|
We have split the talk
into 3 slide show of about 10 megs each. |
|
Part 1 |
|
Part 2 |
|
Part 3 |
|
|
|
|
|
|
CBack
To Topomplex |
|
|
|
|
|
opBack
To Toptimal |
|
TREATMENT BASED ON
OPTIMAL LEVELS DOES NOT WORK |
| How not to use
5-HTP, tyrosine, levodopa, and cysteine in treatment of depression |
|
|
Trying for Optimal
Does Not Work |
|
Part 1 |
|
|
|
|
|
|
basBack
To Topeline |
|
SEROTONIN AND DOPAMINE
URINARY neurotransmitter testing-THE NEW KNOWLEDGE |
|
|
|
|
|
|
|
UBack
To TopNT |
|
SEROTONIN AND DOPAMINE
URINARY neurotransmitter testing-THE NEW KNOWLEDGE |
|
|
|
Urinary
Neurotransmitters |
|
We have split the talk
into 4 slide show of about 10 megs each. |
|
Part 1 |
|
Part 2 |
|
Part 3 |
|
|
|
|
|
seBack
To Top |
|
SIDE EFFECT
MANAGEMENT |
|
Side Effect
Management |
|
We have split the talk
into 3 slide show of about 10 megs each. |
|
Part 1 |
|
Part 2 |
|
Part 3 |
|
|
|
|
Back To
Top |
|
|